OGN
$13.76+0.07%
Organon & Co. Common StockStock · HealthcareRussell 1000 · 0.005% of IWBUS Stock Market · 0.005% of VTIRussell 3000 · 0.005% of IWV
OGN financial statements
The full income statement, balance sheet, and cash-flow statement for Organon & Co. Common Stock (OGN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 257.5M2024-09 257.5M2024-12 258.0M2025-03 260.0M2025-06 260.0M2025-09 260.0M2025-12 260.3M2026-03 262.6M2026-06 262.6M+2.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 6.22B-2.9% | 6.40B+2.2% | 6.26B+1.4% | 6.17B-2.1% | 6.30B-3.5% | |
| 3.31B-10.8% | 3.71B-0.9% | 3.75B-3.4% | 3.88B | — | ||
| Cost of revenue | 2.90B+8.0% | 2.69B+6.9% | 2.52B+9.6% | 2.29B-3.7% | 2.38B+12.4% | |
| Research & development | 366M-22.0% | 469M-11.2% | 528M+12.1% | 471M+6.3% | 443M+111.0% | |
| Selling, general & administrative | 1.72B-2.2% | 1.76B-7.0% | 1.89B+11.1% | 1.70B+2.2% | 1.67B+23.0% | |
| Restructuring | 95.0M+206.5% | 31.0M-50.0% | 62.0M+121.4% | 28.0M+833.3% | 3.00M-95.0% | |
| Amortization of intangibles | 205M+41.4% | 145M+25.0% | 116M+0.0% | 116M+12.6% | 103M+19.8% | |
| Interest expense | 504M-3.1% | 520M-1.3% | 527M+24.9% | 422M+63.6% | 258M | |
| Pre-tax income | 425M-47.3% | 807M+19.9% | 673M-40.0% | 1.12B-26.6% | 1.53B-44.4% | |
| Income tax | 238M+517.5% | -57.0M+83.7% | -350M-270.7% | 205M+15.2% | 178M-64.1% | |
| 187M-78.4% | 864M-15.5% | 1.02B+11.6% | 917M-32.1% | 1.35B-37.5% | ||
| Income from continuing operations | — | — | 1.02B+11.6% | 917M-32.1% | 1.35B-40.1% | |
| $0.72-78.4% | $3.33-16.5% | $3.99+11.1% | $3.59-32.4% | $5.31-37.7% | ||
| EPS (basic) | $0.72-78.6% | $3.36-16.2% | $4.01+11.1% | $3.61-32.3% | $5.33-37.4% | |
| Weighted-avg shares (basic) | 259M+1.0% | 257M+0.7% | 255M+0.5% | 254M+0.2% | 254M+0.0% | |
| Weighted-avg shares (diluted) | 261M+0.6% | 259M+1.1% | 256M+0.4% | 255M+0.4% | 254M+0.3% | |
| Dividends per share | $0.34-69.6% | $1.12+0.0% | $1.12+0.0% | $1.12+100.0% | $0.56 | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 4.35B+0.1% | 4.35B-3.5% | 4.51B+14.7% | 3.93B+4.5% | 3.76B+5.4% | ||
| Cash & equivalents | 574M-15.0% | 675M-2.6% | 693M-1.8% | 706M-4.2% | 737M+6041.7% | |
| Accounts receivable | 1.33B-2.0% | 1.36B-22.1% | 1.74B+18.2% | 1.48B+6.7% | 1.38B+33.1% | |
| Inventory | 1.41B+6.4% | 1.32B+0.5% | 1.31B+31.1% | 1.00B+9.6% | 915M+0.2% | |
| Other current assets | 1.03B+3.9% | 994M+31.5% | 756M+1.2% | 747M+2.9% | 726M-21.9% | |
| 12.9B-1.8% | 13.1B+8.6% | 12.1B+10.1% | 11.0B+2.6% | 10.7B+5.7% | ||
| Property, plant & equipment | 1.30B+11.6% | 1.17B-1.3% | 1.18B+16.2% | 1.02B+4.6% | 973M-1.1% | |
| Operating lease right-of-use | 155M-1.3% | 157M-9.2% | 173M-19.5% | 215M-6.5% | 230M+641.9% | |
| Goodwill | 4.15B-11.3% | 4.68B+1.7% | 4.60B+0.0% | 4.60B+0.0% | 4.60B+0.0% | |
| Intangible assets | 1.13B-20.1% | 1.41B+165.3% | 533M-17.9% | 649M-0.3% | 651M+29.4% | |
| 2.39B-12.1% | 2.72B-6.9% | 2.92B+16.2% | 2.51B-3.3% | 2.60B-2.8% | ||
| Accounts payable | 952M-17.4% | 1.15B-12.3% | 1.31B+16.1% | 1.13B-18.1% | 1.38B+433.6% | |
| Short-term & current debt | 16.0M-20.0% | 20.0M+122.2% | 9.00M+12.5% | 8.00M-11.1% | 9.00M | |
| Current lease liability | 40.0M-9.1% | 44.0M-4.3% | 46.0M-6.1% | 49.0M+6.5% | 46.0M+475.0% | |
| 12.1B-4.1% | 12.6B+4.1% | 12.1B+2.4% | 11.8B | — | ||
| Long-term debt | 8.63B-2.6% | 8.86B+1.2% | 8.75B-1.7% | 8.90B-2.4% | 9.13B | |
| Non-current lease liability | 116M+3.6% | 112M-10.4% | 125M-16.7% | 150M-18.5% | 184M+700.0% | |
| Operating lease liability (total) | 156M+0.0% | 156M-8.8% | 171M-14.1% | 199M-13.5% | 230M+641.9% | |
| Deferred tax liabilities | 57.0M-23.0% | 74.0M+57.4% | 47.0M+147.4% | 19.0M+375.0% | 4.00M-96.9% | |
| Other non-current liabilities | 1.01B+3.2% | 977M+137.1% | 412M+0.2% | 411M-11.2% | 463M-73.4% | |
| 752M+59.3% | 472M+774.3% | -70.0M+92.2% | -892M+40.8% | -1.51B-127.5% | ||
| Common stock | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M+0.0% | 3.00M | |
| Additional paid-in capital | 167M+54.6% | 108M+332.0% | 25.0M | 0.00 | 0.00 | |
| Retained earnings | 1.11B+9.8% | 1.01B+128.0% | 443M+233.8% | -331M+66.8% | -998M | |
| Accumulated other comprehensive income | -527M+18.8% | -649M-20.0% | -541M+4.1% | -564M-9.9% | -513M+17.5% | |
| Total liabilities & equity | 12.9B-1.8% | 13.1B+8.6% | 12.1B+10.1% | 11.0B+2.6% | 10.7B+5.7% | |
| Common shares issued | 260M+1.0% | 258M+0.9% | 256M+0.5% | 254M+0.3% | 254M | |
| Common shares outstanding | 260M+1.0% | 258M+0.9% | 256M+0.5% | 254M+0.3% | 254M | |
| Shares outstanding (cover) | 260M+0.9% | 258M+0.9% | 256M+0.5% | 254M+0.3% | 254M | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 700M-25.5% | 939M+17.5% | 799M-6.9% | 858M-60.3% | 2.16B-5.4% | ||
| Depreciation & amortization | 361M+30.3% | 277M+17.4% | 236M+11.3% | 212M+8.7% | 195M+37.3% | |
| Intangible amortization | 205M+41.4% | 145M+25.0% | 116M+0.0% | 116M+12.6% | 103M+19.8% | |
| Share-based compensation | 77.0M-26.7% | 105M+4.0% | 101M+34.7% | 75.0M+27.1% | 59.0M+47.5% | |
| Deferred income taxes | 63.0M+139.4% | -160M+67.0% | -485M-2594.4% | -18.0M+93.8% | -288M-800.0% | |
| Change in receivables | -79.0M+79.4% | -383M-280.7% | 212M+72.4% | 123M-55.6% | 277M+2230.8% | |
| Change in inventory | 13.0M-90.1% | 131M-43.0% | 230M+4.5% | 220M+59.4% | 138M+505.9% | |
| -390M+24.0% | -513M-97.3% | -260M+38.1% | -420M | — | ||
| Capital expenditure | 162M-7.4% | 175M-30.3% | 251M+28.1% | 196M+2.1% | 192M-24.7% | |
| Free cash flow | 538M-29.6% | 764M+39.4% | 548M-17.2% | 662M-66.4% | 1.97B-3.0% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 1.00M-75.0% | 4.00M+300.0% | 1.00M-85.7% | 7.00M+0.0% | 7.00M+40.0% | |
| -561M-52.4% | -368M+35.3% | -569M-31.4% | -433M | — | ||
| Long-term debt issued | 1.05B-11.0% | 1.19B+1382.5% | 80.0M | 0.00-100.0% | 9.47B | |
| Long-term debt repaid | 1.51B+26.4% | 1.20B+254.1% | 338M+213.0% | 108M-3.6% | 112M | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 88.0M-70.4% | 297M+1.0% | 294M+1.4% | 290M+100.0% | 145M | |
| FX effect on cash | 150M+297.4% | -76.0M-547.1% | 17.0M+147.2% | -36.0M-256.5% | 23.0M | |
| Net change in cash | -101M-461.1% | -18.0M-38.5% | -13.0M+58.1% | -31.0M-104.6% | 667M+367.9% | |
| Income taxes paid | 287M-2.0% | 293M+117.0% | 135M-36.9% | 214M+63.4% | 131M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.87B-51.5% | 3.85B+4.4% | 3.69B-48.1% | 7.10B-8.0% | 7.72B | |
| P/E | 10.0×+124.1% | 4.5×-29.3% | 6.3×-10.3% | 7.0×+22.9% | 5.7× | |
| P/S | 0.3×-50.0% | 0.6×+0.3% | 0.6×-46.9% | 1.1×-7.8% | 1.2× | |
| P/B | 2.5×-69.6% | 8.2× | — | — | — | |
| P/FCF | 3.5×-31.1% | 5.0×-40.7% | 8.5×-46.7% | 15.9×+305.9% | 3.9× | |
| Earnings yield | 10.0%-55.4% | 22.4%+41.4% | 15.9%+11.5% | 14.2%-18.6% | 17.5% | |
| FCF yield | 28.8%+45.2% | 19.9%+68.6% | 11.8%+87.6% | 6.3%-75.4% | 25.5% | |
| Dividend yield | 4.7%-36.8% | 7.5%-3.4% | 7.8%+93.7% | 4.0%+118.0% | 1.8% | |
| Source filing | 10-K | 10-K/A | 10-K | 10-K | 10-K |
About this data
Source: OGN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all OGN filings on SEC EDGAR → Not investment advice.